冠心病是常见的心血管疾病,长期的炎症反应促使患者病情进展与死亡风险增加,残余炎症风险是比低密度脂蛋白胆固醇更强的主要心血管不良事件预测因子。本文从炎症与冠心病的关系入手,结合国内外抗炎治疗方面的最新研究进展,探讨建立残余...冠心病是常见的心血管疾病,长期的炎症反应促使患者病情进展与死亡风险增加,残余炎症风险是比低密度脂蛋白胆固醇更强的主要心血管不良事件预测因子。本文从炎症与冠心病的关系入手,结合国内外抗炎治疗方面的最新研究进展,探讨建立残余炎症风险评估指导下的冠心病二级预防策略。Coronary heart disease is a common cardiovascular condition. The long-term inflammatory response of patients contributes to the progression of the disease and an increased risk of death. Residual inflammatory risk is a stronger predictor of cardiovascular adverse events than low density lipoprotein cholesterol. The secondary prevention strategies of coronary heart disease under the guidance of residual inflammation risk assessment were discussed according to the relationship between inflammation and coronary heart disease as well as the latest clinical research advances in the anti-inflammatory treatment.展开更多
文摘冠心病是常见的心血管疾病,长期的炎症反应促使患者病情进展与死亡风险增加,残余炎症风险是比低密度脂蛋白胆固醇更强的主要心血管不良事件预测因子。本文从炎症与冠心病的关系入手,结合国内外抗炎治疗方面的最新研究进展,探讨建立残余炎症风险评估指导下的冠心病二级预防策略。Coronary heart disease is a common cardiovascular condition. The long-term inflammatory response of patients contributes to the progression of the disease and an increased risk of death. Residual inflammatory risk is a stronger predictor of cardiovascular adverse events than low density lipoprotein cholesterol. The secondary prevention strategies of coronary heart disease under the guidance of residual inflammation risk assessment were discussed according to the relationship between inflammation and coronary heart disease as well as the latest clinical research advances in the anti-inflammatory treatment.
